V-type starch-galloyl-based polyphenol complex stimulates GLP-1 and PYY secretion and improves satiety in mice
Yimei Zheng1, Tonglin Chen1, Ke Li1
1Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, 483 Wushan Road, Guangzhou 510642, China.
Abstract:
Galloyl-based polyphenols including gallic acid (GA) and tannic acid (TA) were used to form complexes with high-amylose maize starch (HAMS). The relationship among complex structure, starch digestibility in vitro, and postprandial glycemic response, hormone concentration and satiety in mice were investigated. Both GA and TA interacted with starch through noncovalent bonds and formed complexes with V-type crystalline structure. The polyphenol loading content in HAMS-TA was higher than HAMS-GA, probably because TA has more galloyl moieties. In vitro digestion revealed HAMS-TA/GA complexes had lower digestion rate (k) and proportion of digestible starch (C∞) than control samples, attributing to their higher crystallinity and inhibition on α-amylase. HAMS-TA had lower k and C∞ than HAMS-GA, resulted from its higher polyphenol loading content. In vivo digestion in mice indicated complexes had lower glycemic response, higher concentrations of GLP-1 and PYY than control groups. They also showed good ability in decreasing glycemic elevation after a subsequent meal and enhancing satiety. HAMS-TA exhibited better performance than HAMS-GA. The in vitro and in vivo results are in good agreements, suggesting the potential ability of starch-galloyl-based polyphenol complexes, especially HAMS-TA complex, in preventing type-2 diabetes and obesity. These would provide guidance for developing starchy foods with functional properties.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Glinides
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...


